COMMUNIQUÉS West-GlobeNewswire

Hyperion DeFi Enters Into First HAUS Agreement With Proprietary Trading Firm Credo
16/09/2025
Generates Additional Yield for 100,000 HYPE Currently Staked by the Company LAGUNA HILLS, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. [...]
SpyGlass Pharma Appoints Anand Sundaram as Head of Commercial
16/09/2025
ALISO VIEJO, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma, a late-stage biopharmaceutical company, today announced the appointment of Anand Sundaram as the company’s Vice President, Head of Commercial. Mr [...]
HCW Biologics Designates One of Its Proprietary TRBC-Pembrolizumab-Based Immune Checkpoint Inhibitors as its Franchise Immunotherapeutic for Internal Clinical Development
16/09/2025
Lead product candidate will be advanced to late IND-enabling studies to prepare for clinical trials for evaluation in the treatment of solid tumors Discovery of unique combination of cytokines in multi-functional fusion [...]
KFSHRC réduit de 75 % le temps d’attente aux urgences pour obtenir une hospitalisation
16/09/2025
RIYAD, Arabie saoudite, 16 sept. 2025 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSHRC) à Riyad a réduit le temps d’attente médian aux urgences, qui est passé de plus de 13 heures en [...]
SCIENTURE Secures PBM-Led GPO Rebate Agreement to Drive Expanded Commercial Coverage and Formulary Access for Arbli™(losartan potassium) in the $256M U.S. Losartan Market
16/09/2025
Arbli ™ is the first and only ready-to-use liquid formulation of losartan, eliminating the need for compounding while offering reduced dosing volume and extended room-temperature shelf life COMMACK, NY, Sept. 16, 2025 ( [...]
Silo Pharma Announces Initial Investment in Ethereum and Solana under Cryptocurrency Treasury Strategy
16/09/2025
Strategic capital deployment advances Company’s blockchain treasury model and biopharma development initiatives SARASOTA, FL, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company [...]
Jyong Biotech Announces Completion of Patient Enrollment of over 700 subjects in Phase II Clinical Trial of MCS‑8 for Prostate Cancer Prevention
16/09/2025
New Taipei City, Taiwan, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company”, “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and [...]
TOMI Environmental Solutions to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2025 on September 16–17, 2025
16/09/2025
FREDERICK, Md., Sept. 16, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier Binary Ionization [...]
BrainsWay Receives FDA Clearance for Accelerated Deep TMS Protocol for Non-Invasive Treatment of Major Depressive Disorder (MDD)
16/09/2025
Clinical data shows that BrainsWay’s new accelerated stimulation protocol is comparable to standard Deep TMS in depression score improvement, response and remission The accelerated protocol is now commercially available [...]
PolyPid Successfully Completes Israeli Ministry of Health GMP Inspection, Advancing Towards Commercial Manufacturing Readiness for D-PLEX₁₀₀
16/09/2025
Key Manufacturing Milestone Strengthens PolyPid’s Position as it Advances Towards Global Commercialization of D-PLEX₁₀₀ Following Successful SHIELD II Phase 3 Trial PETACH TIKVA, Israel, Sept. 16, 2025 (GLOBE NEWSWIRE [...]
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Building Breakthrough Portfolio Aimed at Transforming Cancer, Rare Disease Treatments
16/09/2025
NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the [...]
Clover Health Launches New Portal Availity® Essentials™ to Empower Providers and Improve the Patient Experience
16/09/2025
Clover Health Continues to Invest in Streamlining Provider Workflows and Reducing Administrative Burden Through Technology and Operational Improvements WILMINGTON, Del., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Clover Health [...]
Commure Ambient AI Embedded in MEDITECH Expanse Now, Unlocks Seamless Mobile Documentation for Clinicians
16/09/2025
MOUNTAIN VIEW, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Commure , a leading healthcare technology company, today announced the seamless integration and direct embedding of its Ambient technology within MEDITECH [...]
CytoDyn to Present at the AACR Special Conference: Mechanisms of Cancer Immunity and Cancer-related Autoimmunity
16/09/2025
VANCOUVER, Washington, Sept. 16, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody [...]
SS Innovations Announces Successful Completion of World’s First Pediatric Pyeloplasty Telesurgery Utilizing the Company’s SSi Mantra Surgical Robotic System
16/09/2025
Showcases SSi Mantra’s strengths in robotic telesurgery and opportunity in pediatrics FORT LAUDERDALE, Fla., Sept. 16, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) ( [...]
The International Myeloma Foundation and IMF Nurse Leadership Board Inaugurate NLB Leadership and Mentorship Award
16/09/2025
Honors IMF NLB Member Dr. Beth Faiman as First Recipient During the Inauguration and Awards Ceremony CLEVELAND, Ohio, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) and the IMF Nurse [...]
Sartell Pediatrics Joins Zarminali Pediatrics, Advancing a Shared Commitment to Elevated Multispecialty Care
16/09/2025
Dr. David Smith and his Minnesota-based team becomes the first in the Zarminali network to deliver specialty care, pioneering a new national model ST.CLOUD, Minn., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Zarminali Pediatrics [...]
Birches Health Announces $20M Investment From AlleyCorp, General Catalyst, and Will Ventures to Lead Fight Against Gambling Addiction
16/09/2025
NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Birches Health , the leading national provider of gambling addiction treatment, announced today that it had raised $20 million in combined Series A and Seed funding. The [...]
Relmada Regains Compliance with Nasdaq Minimum Bid Price Requirement
16/09/2025
CORAL GABLES, Fla., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology-related [...]

Pages